FDA NDC Directory · JSON-LD · Markdown

ATOVAQUONE

NDC 73190-098 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerAvKARE
Marketing categoryAbbreviated NDA (generic) · App ANDA202960
Dosage form / routeSUSPENSION · ORAL
Active ingredientsATOVAQUONE (750 mg/5mL)
Marketing started20260614
Package count1

External sources

Source: openFDA. Public-domain (CC0).